Navigation Links
Excellence in Scientific Innovation and Humanitarian Efforts Honored at 2011 Prix Galien Award Ceremony
Date:9/28/2011

NEW YORK, Sept. 28, 2011 /PRNewswire/ -- The Prix Galien USA committee recognized excellence in scientific innovation that improves the state of human health last night during the fifth annual Prix Galien Awards Gala. The Pro Bono Humanum Award and the Prix Galien USA 2011 Awards for best biotechnology product and best pharmaceutical agent were presented at a ceremony held at the Museum of Natural History in New York City.  

The Prix Galien USA 2011 Award selection committee is an unrivaled network that includes seven Nobel Laureates in medicine and is led by Peace Prize winner, Professor Elie Wiesel.  This year the committee honored Dr. Paul Farmer as the recipient of the 2011 Pro Bono Humanum award for his lifetime of humanitarian efforts in Haiti and throughout the world, while also advancing the fight against infectious diseases, including AIDS and tuberculosis.  

"Dr. Farmer is an exemplary model of how one person can be a catalyst between science, business and government to serve as a beacon of hope to those in need," said Mr. Wiesel. "Dr. Farmer's dedication to combating deadly diseases while fighting poverty and inequality in developing countries is inspirational."

In recognition of the development and discovery of biotechnology products that improve the human condition, the selection committee awarded Janssen Biotech, Inc.'s Stelara® and Amgen's Prolia® each with the 2011 Prix Galien USA Award for Best Biotechnology Product.  Stelara®, from Janssen Biotech, Inc., is a treatment for plaque psoriasis that may help provide clearer skin and relief from symptoms, including plaque thickness, scaling, and redness. Amgen's Prolia® is the first and only prescription therapy for postmenopausal osteoporosis that is given as one shot every six months in a doctor's office.

For pharmaceutical advancements, the 2011 Prix Galien USA Award for Best Pharmaceutical Agent was awarded to Pfizer's Prevnar 13®, a pediatric vaccine that helps protect against 13 strains of pneumococcal bacteria.

"The development of these innovative solutions will inform future developments in the fields of biotechnology and pharmaceuticals for years to come," said Gerald Weissmann, M.D., Prix Galien USA committee chair, Research Professor of Medicine at NYU and editor-in-chief of The FASEB Journal. "It is our honor to recognize and award the technical, scientific and clinical research skills that contributed to the development of the products that received the 2011 Prix Galien Awards."

Support for the Prix Galien Awards is provided by Oracle, DDB Healthcare, Proskauer, Cross River Bank, Deloitte, Alexandria Real Estate, Only Lyon, Medidata, Porter Novelli and SAS.

The Prix Galien Award recognizes, and is considered the industry's highest accolade, equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007.

For details about the Prix Galien USA award and committee, visit www.galienfoundation.org.

CONTACT:
Mary Heather
Porter Novelli for Prix Galien USA
+1-212-601-8153
Mary.Heather@porternovelli.com


'/>"/>
SOURCE Prix Galien USA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children
2. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
3. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
4. PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
5. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
6. Roche Scientist Recognized for Excellence in Peptide Chemistry
7. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
8. Ikaria Receives Award for Excellence by New Jersey Business & Industry Association
9. Call for Applications: The Amgen Award for Science Teaching Excellence
10. Giant Eagle(R) Pharmacy Receives Award for Operational Excellence
11. Zimmer Natural Knee Celebrates 25 Years of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company ... severe, rare diseases, today announced that senior management will participate in ... Conference at the InterContinental Barclay Hotel in New York ... ET. About aTyr Pharma ... aTyr Pharma is engaged in the ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, Inc. ... (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to ... for the treatment of bacterial infections including those ... recognized as an attractive antibacterial target for more ... of suitable chemical starting points has hampered its ...
(Date:12/8/2016)... -- The global biosurgery market is expected to grow at ... 2016 to 2021. The market is poised to reach ... in 2016. The market is primarily driven by rising ... and spinal problems, increasing clearance of biosurgery products by ... management. In this report, the biosurgery market ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... The Florida Hospital Tampa Wound Healing ... Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute ... and facilities have earned this distinction. This is the second time the Florida ...
(Date:12/8/2016)... JENNERSVILLE, Pa. (PRWEB) , ... December 08, 2016 ... ... Penn Medicine Southern Chester County, a Property owned by an affiliate of Seavest, ... 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman ... law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at ... DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology Group ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
Breaking Medicine News(10 mins):